NCT05631041View on ClinicalTrials.gov

Effect of Silymarin in Metastatic Colorectal Cancer Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 31, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Silymarin

participants in silymarin group will receive silymarin 140 mg once daily.

Trial Locations (1)

Unknown

RECRUITING

faculty of Pharmacy , Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER